CEL-SCI Corporation (NYSE:CVM) reported first quarter fiscal year 2023 results on February 15, 2023 and filed its Form 10-Q with the SEC. The company has continued to compile the clinical ...
CEL-SCI Corporation (NYSE:CVM) reported fiscal year 2023 on December 22nd after filing its Form 10-K with the SEC the previous day. 2023 has been a busy year for the company with many scientific ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback